Oncology
Uniting for Blood Cancer Awareness
This September, we are showing our support for the blood cancer communities through education, awareness and continued research to address the unmet needs of those affected by these diseases, including advancements in diagnosis and care.
Investors
We announced our quarter 2 2025 results on Wednesday, July 30th.
Press releases
- Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhea
- GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
- GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab mafodotin-blmf) in relapsed/refractory multiple myeloma

GSK Global links
Visit our Global site for additional features